Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

Clinical trial NCT05028829 · RECRUITING

Trial details

NCT number: NCT05028829
Sponsor: Raymond Chung
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Fibroses Cirrhosis

Start date: 2023-05-10
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.